# A Phase I Clinical Trial to Evaluate CU-10101 Unguent

> **NCT06744569** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Cutia Therapeutics（Wuxi）Co.,Ltd** · enrollment: 64 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** CU-10101

## Key facts

- **NCT ID:** NCT06744569
- **Lead sponsor:** Cutia Therapeutics（Wuxi）Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-09-12
- **Primary completion:** 2026-09-09
- **Final completion:** 2026-09-09
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06744569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06744569, "A Phase I Clinical Trial to Evaluate CU-10101 Unguent". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06744569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*